Globus Medical (GMED) Net Margin (2011 - 2026)

Globus Medical has reported Net Margin for 16 years, with the latest figure at 16.36% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 374.0% year-over-year to 16.36%; the trailing twelve-month figure through Mar 2026 stood at 18.92% (up 1153.0% YoY), and the FY2025 full-year result was 18.3%, up 1421.0% from the prior year.
• Net Margin for Q1 2026 stood at 16.36%, down from 17.01% in the prior quarter.
• The five-year high for Net Margin was 27.22% in Q2 2025, with the low at 1.17% in Q1 2024.
• Historically, Net Margin has averaged 12.42% across 5 years, with a median of 15.47% in 2025.
• Annual changes were most pronounced in 2024 — Net Margin sank 1893 bps — and 2025, when it surged 2217 bps.
• Globus Medical's Net Margin stood at 10.1% in 2022, then sank by 76 bps to 2.44% in 2023, then jumped by 65 bps to 4.03% in 2024, then surged by 322 bps to 17.01% in 2025, then retreated by 4 bps to 16.36% in 2026.
• The last three Net Margin figures came in at 16.36% (Q1 2026), 17.01% (Q4 2025), and 15.47% (Q3 2025), per Business Quant data.